Health Care & Life Sciences » Pharmaceuticals | Medical Developments International Ltd.

Medical Developments International Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
9,370.00
11,608.00
15,471.00
18,347.00
17,461.00
Cost of Goods Sold (COGS) incl. D&A
3,145.00
3,698.00
5,070.00
6,768.00
6,259.00
Gross Income
6,225.00
7,910.00
10,401.00
11,579.00
11,202.00
SG&A Expense
5,073.00
4,825.00
6,841.70
8,043.00
9,691.00
EBIT
594.00
-
3,559.30
3,536.00
1,511.00
Unusual Expense
-
-
238.30
-
-
Non Operating Income/Expense
25.00
944.00
1,018.00
1,077.00
1,071.00
Interest Expense
-
81.00
24.00
7.00
140.00
Pretax Income
641.00
2,176.00
2,301.00
2,463.00
301.00
Income Tax
234.00
647.00
732.00
643.00
58.00
Consolidated Net Income
875.00
1,529.00
1,569.00
1,820.00
243.00
Net Income
875.00
1,529.00
1,569.00
1,820.00
243.00
Net Income After Extraordinaries
875.00
1,529.00
1,569.00
1,820.00
243.00
Net Income Available to Common
875.00
1,529.00
1,569.00
1,820.00
243.00
EPS (Basic)
0.02
0.03
0.03
0.03
0.00
Basic Shares Outstanding
57,639.20
57,725.10
57,798.70
58,711.50
59,080.50
EPS (Diluted)
0.02
0.03
0.03
0.03
0.00
Diluted Shares Outstanding
57,639.20
57,725.10
58,139.60
58,711.50
59,080.50
EBITDA
912.00
3,462.00
4,655.30
4,870.00
3,293.00
Other Operating Expense
558.00
-
-
-
-
Non-Operating Interest Income
22.00
5.00
22.00
11.00
1.00

About Medical Developments International

View Profile
Address
4 Caribbean Drive
Scoresby Victoria (VIC) 3179
Australia
Employees -
Website http://www.medicaldev.com
Updated 07/08/2019
Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. It operates through the following segments: Pharmaceuticals, Medical Equipment, and Veterinary Equipment. The Pharmaceuticals segment involves the selling of Penthrox drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.